Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Todd B, Cole"'
Autor:
Anthony M. Giamis, Andrew Goodearl, Christine Grinnell, Kelly J. Doyle, Katherine Salte, Victor Sun, Todd B. Cole, Murali Gopalakrishnan, L. Olson, Susan E. Lacy, Meha Chhaya, Yanping Luo, Steve McGaraughty, Arthur L. Nikkel, Rachel Davis-Taber, Chang Z. Zhu, Gregory M. Preston
Publikováno v:
Journal of the American Society of Nephrology. 28:3616-3626
Targeted delivery of a therapeutic agent to a site of pathology to ameliorate disease while limiting exposure at undesired tissues is an aspirational treatment scenario. Targeting diseased kidneys for pharmacologic treatment has had limited success.
Autor:
Steve, McGaraughty, Rachel A, Davis-Taber, Chang Z, Zhu, Todd B, Cole, Arthur L, Nikkel, Meha, Chhaya, Kelly J, Doyle, Lauren M, Olson, Gregory M, Preston, Christine M, Grinnell, Katherine M, Salte, Anthony M, Giamis, Yanping, Luo, Victor, Sun, Andrew D, Goodearl, Murali, Gopalakrishnan, Susan E, Lacy
Publikováno v:
Journal of the American Society of Nephrology : JASN. 28(12)
Targeted delivery of a therapeutic agent to a site of pathology to ameliorate disease while limiting exposure at undesired tissues is an aspirational treatment scenario. Targeting diseased kidneys for pharmacologic treatment has had limited success.
Autor:
Jonathan A. Meulbroek, Todd B. Cole, Andrew M. Scott, Neal Goodwin, Kingsbury Gillian A, Devries Peter J, Edward B. Reilly, Enrico L. Digiammarino, Cherrie K. Donawho, Andrew C. Phillips, Hugh D. Falls, Christine Beam, Yumin Zhang, Fritz G. Buchanan, Joann P. Palma, Jinming Gu
Publikováno v:
Molecular cancer therapeutics. 14(5)
Despite clinical efficacy, current approved agents targeting EGFR are associated with on-target toxicities as a consequence of disrupting normal EGFR function. MAb 806 is a novel EGFR antibody that selectively targets a tumor-selective epitope sugges
Autor:
Cherrie K. Donawho, Martin J. Voorbach, Todd B. Cole, Kimberley D. Holich, Sarah R. Mudd, Gail Bukofzer, Gerard B. Fox, David R. Reuter, Yanping Luo, Joann P. Palma, Mark Day, Paul Tapang, Arunava Chakravartty
Publikováno v:
Molecular imaging and biology. 14(5)
Longitudinal changes of 3'-[(18) F]fluoro-3'-deoxythymidine (FLT) and 2-deoxy-2-[(18) F]fluoro-D-glucose (FDG) in response to irinotecan therapy in an animal model of colorectal cancer were compared.SCID/CB-17 mice with HCT116 tumors were treated wit
Autor:
Gerard B. Fox, Evelyn McKeegan, David R. Reuter, Vincent P. Hradil, Todd B. Cole, Yanping Luo, Bryan F. Cox, Fang Jiang, Steven K. Davidsen, Daniel H. Albert, Arunava Chakravartty
Publikováno v:
Cancer chemotherapy and pharmacology. 69(4)
Tyrosine kinase inhibitors represent a class of targeted therapy that has proven to be successful for cancer treatment. Linifanib is a novel, orally active multi-targeted receptor tyrosine kinase (RTK) inhibitor that exhibits potent antitumor and ant
Autor:
Feng Luo, Prasant Chandran, Todd B. Cole, Gerard B. Fox, Jaymin Upadhyay, Chih-Liang Chin, Mark Day, Scott J. Baker, Unal Sakoglu
Publikováno v:
Biochemical pharmacology. 81(12)
During the last two decades, functional neuroimaging technology, especially functional magnetic resonance imaging (fMRI), has improved tremendously, with new attention towards resting-state functional connectivity of the brain. This development has a
Autor:
Terese Seifert, Yumin Zhang, Feng Luo, Gerard B. Fox, Bryan F. Cox, Todd B. Cole, Sarah R. Mudd
Publikováno v:
Alzheimer's & Dementia. 5